H2N2 avian influenza vaccine (GlaxoSmithKline)

H2N2禽流感疫苗（GlaxoSmithKline）

Report date: 2023/02/17 21:17:24

Base Information

Drug NameH2N2 avian influenza vaccine (GlaxoSmithKline)
Drug Alias NameH2N2 influenza vaccineH2N2禽流感疫苗-葛兰素史克
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza in Birds
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsInfluenza in Birds

Other Information

ATC CodeN/A
Related LinksN/A